Quizartinib
| CAS No. | 950769-58-1 |
|---|---|
| MDL No. | MFCD18074524 |
| MF | C29H32N6O4S |
| MW | 560.70 |
| InChI Key | CVWXJKQAOSCOAB-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Quizartinib is a phenylurea in which one amino group is substituted by a 5-tert-butyl-1,2-oxazol-3-yl group and the other by a para-imidazo[2,1-b][1,3]benzothiazol-2-ylphenyl group, which is further substituted at position 7 by a 2-(morpholin-4-yl)ethoxy group. It functions as an EC 2.7.10.1 receptor protein-tyrosine kinase inhibitor, an antineoplastic agent, and a necroptosis inhibitor. It is classified as a benzoimidazothiazole, a morpholine, an isoxazole, and a phenylurea.
| CAS No. | 950769-58-1 |
|---|---|
| Product Name | Quizartinib |
Biological Targets
CSF1R·PDGFRB·PDGFRA·KIT·FLT3·
Associated Conditions
liver disease·neoplasm·childhood leukemia·acute myeloid leukemia·acute myeloid leukemia by FAB classification
* The information provided here is compiled from public sources and is for reference only.
